Free Trial

EssilorLuxottica (ESLOY) Stock Forecast & Price Target

EssilorLuxottica logo
$99.15 -1.29 (-1.28%)
As of 06/2/2026 03:58 PM Eastern

EssilorLuxottica - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Sell
0
Hold
2
Buy
7

Based on 9 Wall Street analysts who have issued ratings for EssilorLuxottica in the last 12 months, the stock has a consensus rating of "Buy." Out of the 9 analysts, 2 have given a hold rating, 5 have given a buy rating, and 2 have given a strong buy rating for ESLOY.

Consensus Price Target

N/A

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for ESLOY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for EssilorLuxottica and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ESLOY Analyst Ratings Over Time

TypeCurrent Forecast
6/3/25 to 6/3/26
1 Month Ago
5/4/25 to 5/4/26
3 Months Ago
3/5/25 to 3/5/26
1 Year Ago
6/3/24 to 6/3/25
Strong Buy
2 Strong Buy rating(s)
2 Strong Buy rating(s)
2 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
5 Buy rating(s)
5 Buy rating(s)
5 Buy rating(s)
0 Buy rating(s)
Hold
2 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus RatingBuyBuyBuyHold

ESLOY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ESLOY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

EssilorLuxottica Stock vs. The Competition

TypeEssilorLuxotticaMedical CompaniesBroader Market
Consensus Rating Score
3.00
2.30
2.52
Consensus RatingBuyHoldModerate Buy
Predicted UpsideN/A1,731.01% Upside15.35% Upside
News Sentiment Rating
Neutral News

See Recent ESLOY News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
5/12/2026 Initiated CoverageHold
1/15/2026 UpgradeHoldBuy
1/14/2026
HSBC Holdings plc logo
HSBC
3 of 5 stars
 UpgradeHoldBuy
12/11/2025 Reiterated RatingBuy
12/5/2025 Reiterated RatingBuy
11/27/2025 UpgradeHoldStrong-Buy
11/18/2025 DowngradeStrong-BuyHold
10/28/2025 Reiterated RatingOutperform
9/9/2025 Initiated CoverageOverweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 02:08 AM ET.


Should I Buy EssilorLuxottica Stock? ESLOY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, May 29, 2026. Please send any questions or comments about these EssilorLuxottica pros and cons to contact@marketbeat.com.

EssilorLuxottica
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in EssilorLuxottica Société anonyme:

  • The current stock price is around $120.51, which may present a favorable entry point for investors looking to capitalize on potential growth.
  • EssilorLuxottica Société anonyme has a diverse product portfolio, including well-known brands like Ray-Ban and Oakley, which can attract a wide customer base and drive sales.
  • The company operates in multiple regions, including Europe, North America, and Asia-Pacific, providing a broad market reach and reducing dependency on any single market.
  • With a focus on innovation, EssilorLuxottica Société anonyme continues to develop advanced eyewear technologies, enhancing customer experience and potentially increasing market share.
  • The company has a strong presence in both wholesale and direct-to-consumer channels, allowing for flexibility in sales strategies and revenue generation.

EssilorLuxottica
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in EssilorLuxottica Société anonyme for these reasons:

  • There is a relatively high short interest in the stock, with a short percentage of float indicating some investors are betting against the company's performance.
  • Institutional ownership is currently at 0%, which may suggest a lack of confidence from larger investors in the company's future prospects.
  • The company has experienced fluctuations in its average daily volume, which could indicate volatility and uncertainty in investor sentiment.
  • Recent performance metrics show no significant gains over the past year, which may raise concerns about the company's growth trajectory.
  • As the market for eyewear becomes increasingly competitive, EssilorLuxottica Société anonyme may face challenges in maintaining its market position against emerging brands.

ESLOY Forecast - Frequently Asked Questions

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for EssilorLuxottica in the last twelve months. There are currently 2 hold ratings, 5 buy ratings and 2 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ESLOY shares.

According to analysts, EssilorLuxottica's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

EssilorLuxottica has been rated by research analysts at Deutsche Bank Aktiengesellschaft in the past 90 days.

Analysts like EssilorLuxottica more than other "medical" companies. The consensus rating for EssilorLuxottica is Buy while the average consensus rating for "medical" companies is Hold. Learn more on how ESLOY compares to other companies.


This page (OTCMKTS:ESLOY) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners